327 related articles for article (PubMed ID: 21536946)
1. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
[TBL] [Abstract][Full Text] [Related]
3. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
[TBL] [Abstract][Full Text] [Related]
4. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
[TBL] [Abstract][Full Text] [Related]
5. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
Faletra F; Snider K; Shyng SL; Bruno I; Athanasakis E; Gasparini P; Dionisi-Vici C; Ventura A; Zhou Q; Stanley CA; Burlina A
Gene; 2013 Mar; 516(1):122-5. PubMed ID: 23266803
[TBL] [Abstract][Full Text] [Related]
6. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
[TBL] [Abstract][Full Text] [Related]
8. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
[TBL] [Abstract][Full Text] [Related]
9. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
[TBL] [Abstract][Full Text] [Related]
10. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
[TBL] [Abstract][Full Text] [Related]
12. KATP channel mutations in congenital hyperinsulinism.
Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
[TBL] [Abstract][Full Text] [Related]
14. Prematurity, macrosomia, hyperinsulinaemic hypoglycaemia and a dominant ABCC8 gene mutation.
Khoriati D; Arya VB; Flanagan SE; Ellard S; Hussain K
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23563683
[TBL] [Abstract][Full Text] [Related]
15. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.
Ohkubo K; Nagashima M; Naito Y; Taguchi T; Suita S; Okamoto N; Fujinaga H; Tsumura K; Kikuchi K; Ono J
Clin Endocrinol (Oxf); 2005 Apr; 62(4):458-65. PubMed ID: 15807877
[TBL] [Abstract][Full Text] [Related]
16. [Congenital hyperinsulinism in newborn and infant].
Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism.
Lee CT; Tsai WH; Chang CC; Chen PC; Fann CS; Chang HK; Liu SY; Wu MZ; Chiu PC; Hsu WM; Yang WS; Lai LP; Tsai WY; Yang SB; Chen PL
Front Endocrinol (Lausanne); 2023; 14():1283907. PubMed ID: 38033998
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.
Henwood MJ; Kelly A; Macmullen C; Bhatia P; Ganguly A; Thornton PS; Stanley CA
J Clin Endocrinol Metab; 2005 Feb; 90(2):789-94. PubMed ID: 15562009
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
[TBL] [Abstract][Full Text] [Related]
20. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
